文献速递甲状腺疾病

早产儿先天性甲状腺功能减退症的新生儿筛查:是否需要针对性策略?

Neonatal Screening for Congenital Hypothyroidism in Preterm Infants: Is a Targeted Strategy Required?
PubMed 文献 · Thyroid · 2023-03-17

这项回顾性队列研究描述了意大利皮埃蒙特大区2019年1月至2021年12月5930名早产新生儿的先天性甲状腺功能减退症(CH)筛查结果,首次TSH测量在72小时、第二次在15日龄,召回阈值分别为>20 mUI/L和>6 mUI/L。研究观察到早产儿与足月儿召回率无显著差异,CH发病率为1:156,作者认为现行筛查策略似乎有效,但需开发并测试统一的跨国筛查策略。

要点

  • 早产儿按出生体重和胎龄分组的平均TSH在首次检测时存在显著差异(p<0.005)。
  • 本队列99%参考范围与推荐的筛查召回TSH切点(首次8 mUI/L、第二次6 mUI/L)重叠。
  • CH发病率为1:156,38例确诊者中30例(87.9%)为原位腺体,29例(76.8%)为一过性CH。

核心结论

  • 本研究中早产儿与足月儿的召回率无显著差异,现行筛查策略似乎有效避免了误诊。
  • CH筛查方法各国不同,需要开发并测试统一的跨国筛查策略。

研究设计与样本

  • 回顾性队列研究,纳入意大利皮埃蒙特大区2019年1月至2021年12月期间接受新生儿筛查的所有早产新生儿,共5930名。
  • 首次促甲状腺激素(TSH)测量在72小时进行,第二次在15日龄进行。
  • 首次检测TSH>20 mUI/L且第二次>6 mUI/L的婴儿被召回进行全面甲状腺功能评估。

主要发现

  • 按出生体重分组,首次检测平均TSH:<1000 g组为2.08±0.15 mUI/L,1001-1500 g组为2.01±0.02 mUI/L,1501-2499 g组为2.28±0.03 mUI/L,正常体重新生儿为2.41±0.03 mUI/L(p<0.005),第二次测量也观察到显著差异(p<0.005)。
  • 按胎龄分组,首次检测平均TSH:超早产儿为1.71±0.09 mUI/L,极早产儿为1.87±0.06 mUI/L,中度早产儿为1.94±0.05 mUI/L,晚期早产儿为2.42±0.02 mUI/L(p<0.005);第二次和第三次检测也观察到组间显著差异(p<0.005和p=0.01)。
  • 本队列99%参考范围与推荐的筛查召回TSH切点(首次检测8 mUI/L、第二次检测6 mUI/L)重叠。
  • CH发病率为1:156;38例确诊CH患者中,30例(87.9%)为原位腺体,29例(76.8%)为一过性CH。

关键数值与推荐

  • 首次检测TSH>20 mUI/L且第二次检测TSH>6 mUI/L时召回进行全面甲状腺功能评估。
  • 推荐筛查召回TSH切点:首次检测8 mUI/L,第二次检测6 mUI/L。

临床怎么用

  • 作者认为现行筛查策略(72小时首次检测、15日龄第二次检测,召回阈值分别为>20 mUI/L和>6 mUI/L)似乎有效避免了误诊。
  • 作者提出需要开发并测试统一的跨国筛查策略。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Background: Premature infants are at higher risk of developing congenital hypothyroidism (CH) but the neonatal screening strategy for this population is still debatable. The purpose of this retrospective study is to describe the results of a screening program for CH in a preterm infant cohort. Materials and Methods: All preterm newborns who underwent neonatal screening in the Italian region of Piedmont in the period January 2019-December 2021, were included in this retrospective cohort study. The first thyrotropin (TSH) measurement was performed at 72 hours, whereas the second at 15 days of life. Infants with TSH >20 mUI/L at first detection and >6 mUI/L at second were recalled for a full evaluation of thyroid function. Results: During the study period, 5930 preterm newborns were screened. Based on birthweight (BW), the mean TSH was 2.08 ± 0.15 for BW <1000 g, 2.01 ± 0.02 for BW 1001-1500 g, 2.28 ± 0.03 for BW 1501-2499 g, and 2.41 ± 0.03 mUI/L in normal-weight newborns (p < 0.005) at the first detection, with a significant difference observed at the second measurement (p < 0.005). Based on gestational age, the mean TSH at first detection was 1.71 ± 0.09 mUI/L for extremely preterm babies and 1.87 ± 0.06, 1.94 ± 0.05, and 2.42 ± 0.02 mUI/L for very preterm, moderately, and late preterm infants (p < 0.005), respectively. Significant between-group differences of TSH measurements were also at the second and third detections (p < 0.005 and p = 0.01). The 99% reference range in this cohort overlapped with the recommended TSH cutoffs for screening recall (8 mUI/L for first detection and 6 mUI/L for second detection). CH incidence was 1:156. Of the 38 patients diagnosed with CH, a eutopic gland was present in 30 (87.9%), with CH transient in 29 (76.8%). Conclusions: We observed no significant difference in the recall rate between preterm and at term infants screened in this study. Our current screening strategy therefore appears effective in avoiding misdiagnosis. CH screening approaches vary among countries. Development and testing of a uniform multinational screening strategy is needed.

来源:Thyroid,查看原文。版权归原作者所有。

引用

  1. Tuli G, Munarin J, Topalli K, et al. Neonatal Screening for Congenital Hypothyroidism in Preterm Infants: Is a Targeted Strategy Required? Thyroid. 2023. PMID: 36802847. doi:10.1089/thy.2022.0495

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。